Finland· FI-REL-REL58095

Targocid

A teicoplanin product containing teicoplanin, registered in Finland by Paranova Oy. The same ATC class is registered in 15 of our 19 countries.

ATC J01XA02

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedTargocidATCJ01XA02REGISTER NO.FI-REL-REL58095PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Teicoplanin is registered in 15 of 19 countries.

Countries holding a registration under ATC J01XA02 (teicoplanin), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose

Teicoplanin · ATC J01XA02

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Teicoplanin
Manufacturer
Paranova Oy
Country
Finland (FI)
ATC code
J01XA02
ATC class
Teicoplanin
Defined daily dose
0.4 g, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    389489
    400 mg
    EUR 234.29

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Teicoplanin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All teicoplanin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Teicoplanin Accord, Teicoplanin Altan
  • Belgium · Targocid, Teicoplanin Bradex
  • Bulgaria · Планитек, Планицид
  • Cyprus · Talinac, Teicoplanin Aptapharma
  • Czechia · Targocid, Teicoplanin Aptapharma
  • Germany · Teicoplanin Altan, Teicoplanin Centurion
  • Denmark · Targocid, Teicoplanin Demo S.A.
  • Spain · Targocid, Teicoplanina Accord
  • France · Targocid, Teicoplanine Altan
  • United Kingdom (Northern Ireland) · Targocid, Teicoplanin
  • Greece · Talinac, Targocid
  • Croatia · Targocid, Teikoplanin Aptapharma
  • Hungary · Targocid, Teicoplanin Anfarm
  • Ireland · Targocid, Teicoplanin Hikma
  • Italy · Planicid, Targosid
  • Luxembourg · Targocid
  • Malta · Targocid, Teicoplanin Anfarm
  • Netherlands · Targocid, Teicoplanin Sun
  • Norway · Teicoplanin Demo S.A.
  • Poland · Targocid, Teicoplanin Altan
  • Portugal · Teicoplanina Accord, Teicoplanina Altan
  • Romania · Targocid, Teicoplanină Aptapharma
  • Sweden · Targocid, Teicoplanin Bradex
  • Slovenia · Targocid, Teikoplanin Aptapharma
  • Slovakia · Targocid, Teicoplanin Aptapharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fbd86c4a-f0e5-4807-a08c-22217e2f0656
GET /v1/drugs/fbd86c4a-f0e5-4807-a08c-22217e2f0656?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.4",
  "form": "injektio/infuusiokuiva-aine, liuosta varten ",
  "route": "Suun kautta",
  "ddd_unit": "g",
  "strength": "400 mg",
  "atc_label": "teikoplaniini",
  "ma_number": "39034",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL58095",
  "authorised_at": "2021-10-14"
}

See everything about teicoplanin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.